Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Highlights

A collection of news and information related to Simvastatin (drug) published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-12 of 14
» View wsbtradio.com items only
    Nov 15, 2009 | Los Angeles Times
  1. Vytorin trial shows little or no benefit against heart disease [Updated]

    Booster Shots
    For the second time in as many years, a large clinical trial has found that the key ingredient in the heavily advertised drug Vytorin provides little or no benefit in preventing heart disease compared to a competing product. The ingredient......
  2. Dec 24, 2009 | Los Angeles Times
  3. FDA panel says Vytorin and Zetia probably don't cause cancer

    Booster Shots
    A comprehensive review of previous studies involving the cholesterol-lowering drugs Vytorin and Zetia and two large ongoing studies shows that "it is unlikely that [they] increase the risk of cancer or cancer-related deaths," a Food and Drug...
  4. Mar 19, 2010 | Los Angeles Times
  5. The FDA cautions against high doses of Zocor (simvastatin), urges label changes

    Booster Shots
    The highest doses of the cholesterol-lowering drug Zocor produce an increased risk of muscle damage, the Food and Drug Administration cautioned Friday. The risk is highest in patients of Chinese descent and is also high when Zocor, known generically as......
  6. May 3, 2013 |Story| Reuters
  7. FDA approves Merck combination cholesterol lowering pill

    Reuters
    May 3 (Reuters) - The U.S. Food and Drug Administration approved a Merck & Co cholesterol lowering pill that combines a generic version of Pfizer Inc's Lipitor with its own Zetia, Merck said on Friday. The new combination drug will be sold under the brand...

    Tags: Food and Drug Administration, Zocor (drug), Statins (drugs), Vytorin (drug), Drugs and Medicines

  8. Nov 26, 2012 |Story| Los Angeles Times
  9. Grapefruit doesn't mix well with some drugs, researchers remind

    It’s been known for a long time that eating grapefruit and taking certain prescription oral medications — including the cholesterol drugs atorvastatin, lovastatin and simvastatin as well as some cancer and heart drugs — don’t mix. 
    Los Angeles Times
    It’s been known for a long time that eating grapefruit and taking certain prescription oral medications — including the cholesterol drugs atorvastatin, lovastatin and simvastatin as well as some cancer and heart drugs — don’t mix. ...

    Tags: Prescription Drugs, Chemical Industry, Pharmaceuticals, Statins (drugs), Science and Technology

  10. Nov 30, 2009 |Story| Los Angeles Times
  11. Every drug has risks and information is key to avoiding them

    Some drugs are so common that consumers -- at their peril -- don't think twice about them. But each drug, whether prescription or over-the-counter, poses risks. We offer a few details on five of the most-prescribed medications. Hydrocodone with...

    Tags: Liver, Potassium (dietary supplement), Lisinopril (drug), National Institutes of Health, Levothyroxine (drug)

  12. Nov 30, 2009 |Story| Los Angeles Times
  13. Even the most common medications pose threats

    Some drugs are so common that consumers -- at their peril -- don't think twice about them. But each drug, whether prescription or over-the-counter, poses risks. To highlight these risks, we offer up a few details on five of the most-prescribed medications, with additional input from pharmacists interviewed for this package of stories.
    Some drugs are so common that consumers -- at their peril -- don't think twice about them. But each drug, whether prescription or over-the-counter, poses risks. To highlight these risks, we offer up a few details on five of the most-prescribed...

    Tags: Potassium (dietary supplement), Vitamin Therapy, Drunk Driving, Viral Diseases and Infections, Basketball

  14. Sep 5, 2012 |Story| Chicago Tribune
  15. Study finds evidence that statins can lower the risk of some cancers

    That statin pill you take each day to keep your cholesterol in check may reduce your risk of cancer, too, according to a study in Israel.
    That statin pill you take each day to keep your cholesterol in check may reduce your risk of cancer, too, according to a study in Israel. The study examined data collected from 202,648 adults, ages 21 and older, who were enrolled in an HMO from 1998 to...

    Tags: Tel Aviv (Israel), Lymphoma, Physical Fitness and Exercise, Statins (drugs), Medical Research

  16. Oct 7, 2011 |Story| WPIX-LTV
  17. FDA Approves Combination Therapy Juvisync For Type 2 Diabetes

    The U.S. Food and Drug Administration today approved Juvisync (sitagliptin and simvastatin), a fixed-dose combination (FDC) prescription medication that contains two previously approved medicines in one tablet for use in adults who need both sitagliptin...

    Tags: Food and Drug Administration, Abdominal Pain, Heart Disease, Pharmaceuticals, Chemical Industry

  18. May 26, 2011 |Story| Reuters
  19. |Story
  20. May 26, 2011 |Story| Chicago Breaking Business
  21. |Story
  22. May 27, 2011 |Story| Chicago Breaking Business
  23. |Story
 1  2Next >
Original site for Simvastatin (drug) topic gallery.